×
Insulet Common Stock Net 2010-2025 | PODD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Insulet common stock net for the quarter ending June 30, 2025 was
$0M
, a
0% increase
year-over-year.
Insulet common stock net for 2024 was
$0B
, a
0% decline
from 2023.
Insulet common stock net for 2023 was
$0B
, a
0% decline
from 2022.
Insulet common stock net for 2022 was
$0B
, a
0% decline
from 2021.
View More
Insulet Common Stock Net 2010-2025 | PODD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Insulet common stock net for 2024 was
$0B
, a
0% decline
from 2023.
Insulet common stock net for 2023 was
$0B
, a
0% decline
from 2022.
Insulet common stock net for 2022 was
$0B
, a
0% decline
from 2021.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$230.8B
Boston Scientific (BSX)
$157.3B
Stryker (SYK)
$150.7B
EssilorLuxottica (ESLOY)
$147.8B
Medtronic (MDT)
$118.8B
Lonza Group Ag (LZAGY)
$49.6B
Haleon (HLN)
$44B
ResMed (RMD)
$43B
Agilent Technologies (A)
$34.6B
GE HealthCare Technologies (GEHC)
$34.3B
Terumo (TRUMY)
$27.7B
Koninklijke Philips (PHG)
$27.3B
Zimmer Biomet Holdings (ZBH)
$21.3B
Smith & Nephew SNATS (SNN)
$16.4B
Baxter (BAX)
$12.6B
Sunny Optical Technology (SNPTF)
$10.8B
Bio-Rad Laboratories (BIO)
$8.2B
Demant (WILYY)
$8.1B
Lantheus Holdings (LNTH)
$4B
Envista Holdings (NVST)
$3.6B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Perrigo (PRGO)
$3.4B
Prestige Consumer Healthcare (PBH)
$3.3B
ICU Medical (ICUI)
$3.2B
Haemonetics (HAE)
$2.7B
LeMaitre Vascular (LMAT)
$2.3B
Acuren (TIC)
$2.1B
QuidelOrtho (QDEL)
$1.9B
Curaleaf Holdings (CURLF)
$1.9B
AtriCure (ATRC)
$1.9B